Pitt innovators were issued 5 U.S. patents in September 2024.
Featured patent: 12,0083,144: Dosage Form for Treating Severe Asthma
Severe asthma consumes 40-50% of asthma-related healthcare costs, amounting to $28 billion each year in the US. Corticosteroids, a mainstay of asthma therapy, are ineffective at treating severe asthma, leading to more frequent emergency care and hospitalization.
Pitt innovators have shown that IRF5 expression in dendritic cells, which prime and perpetuate specific immune responses, regulates a cytokine responsible for T cell production of IFN-γ. An intervention aimed at blocking IRF5 function in the lungs of severe asthmatics represents a promising new modality of treating a condition that still goes untreated.
For more information on this technology, including licensing, contact us at partner@pitt.edu.
Below is a listing of all patents issued to Pitt innovators in September 2024. You can also search all Pitt technologies available for licensing.
| Patent number | Title | Inventor(s) | Licensing manager | Status |
|---|---|---|---|---|
| 12,083,144 | Dosage Form for Treating Severe Asthma | Timothy Oriss; Anuradha Ray; Prabir Ray | Maria Vanegas | Available for licensing |
| 12,083,185 | Small Polymeric Carriers for Delivery of Agents | Song Li; Jingjing Sun | Katherine Gadacz | Licensed |
| 12,077,885 | Processing Method and Apparatus for Micro-Structured Rope-Like Material | Antonio D’Amore; Daniel McKeel; William Wagner | Janice Panza | Available for licensing |
| 12,097,645 | Automation Mechanism for Pre/Clinical Production of Resorbable Nerve Guides | Kacey Marra; James Alexander; Benjamin Schilling | Janice Panza | Available for licensing |
| 12,096,863 | Access System | Aivan Almosnino; Joshua Brown; Rory Cooper; Lisa Garamella; Benjamin Gebrosky; Garrett Grindle; Sayeedur Rahman; Daniel Robin; Michael Shulock | George Coulston | Available for licensing |